Trial · NCT04836559
Adverse events424
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 424
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vertigo | Ear and labyrinth disorders | DB: Cohort 1: Placebo | 0 | 20 | |
| other | Vertigo | Ear and labyrinth disorders | DB: Cohort 1: JNJ-40411813 | 0 | 40 | |
| other | Vertigo | Ear and labyrinth disorders | DB: Cohort 2: Placebo | 1 | 9 | |
| other | Vertigo | Ear and labyrinth disorders | DB: Cohort 2: JNJ-40411813 | 5 | 41 | |
| other | Vertigo | Ear and labyrinth disorders | OLE: Cohort 1: Placebo Followed by JNJ-40411813 | 0 | 12 | |
| other | Vertigo | Ear and labyrinth disorders | OLE: Cohort 1: JNJ-40411813 Followed by JNJ-40411813 | 1 | 23 | |
| other | Vertigo | Ear and labyrinth disorders | OLE: Cohort 2: Placebo Followed by JNJ-40411813 | 1 | 7 | |
| other | Vertigo | Ear and labyrinth disorders | OLE: Cohort 2: JNJ-40411813 Followed by JNJ-40411813 | 0 | 31 | |
| other | Diplopia | Eye disorders | DB: Cohort 1: Placebo | 0 | 20 | |
| other | Diplopia | Eye disorders | DB: Cohort 1: JNJ-40411813 | 1 | 40 | |
| other | Diplopia | Eye disorders | DB: Cohort 2: Placebo | 0 | 9 | |
| other | Diplopia | Eye disorders | DB: Cohort 2: JNJ-40411813 | 0 | 41 | |
| other | Diplopia | Eye disorders | OLE: Cohort 1: Placebo Followed by JNJ-40411813 | 0 | 12 | |
| other | Diplopia | Eye disorders | OLE: Cohort 1: JNJ-40411813 Followed by JNJ-40411813 | 1 | 23 | |
| other | Diplopia | Eye disorders | OLE: Cohort 2: Placebo Followed by JNJ-40411813 | 1 | 7 | |
| other | Diplopia | Eye disorders | OLE: Cohort 2: JNJ-40411813 Followed by JNJ-40411813 | 0 | 31 | |
| other | Vision Blurred | Eye disorders | DB: Cohort 1: Placebo | 0 | 20 | |
| other | Vision Blurred | Eye disorders | DB: Cohort 1: JNJ-40411813 | 0 | 40 | |
| other | Vision Blurred | Eye disorders | DB: Cohort 2: Placebo | 0 | 9 | |
| other | Vision Blurred | Eye disorders | DB: Cohort 2: JNJ-40411813 | 0 | 41 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04836559/events